Seres Therapeutics
MCRB
#8981
Rank
S$0.12 B
Marketcap
$0.74
Share price
-3.90%
Change (1 day)
-24.55%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2023 (TTM): -$1.50

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.51. In 2022 the company made an earnings per share (EPS) of -$3.16 a decrease over its 2021 EPS that were of -$0.99.

EPS history for Seres Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.50-52.6%
2022-$3.16220.55%
2021-$0.99-34.23%
2020-$1.50-15.27%
2019-$1.77-46.09%
2018-$3.289.95%
2017-$2.98-3.49%
2016-$3.09-10.19%
2015-$3.44321.85%
2014-$0.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.89 91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.33 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA